Travere Therapeutics, Inc. — All Filings
1,001 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-12G
10-12G/A
10-K
10-K/A
10-Q
10-Q/A
144
3
3/A
305B2
4
4/A
424B1
424B3
424B5
5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
EFFECT
FWP
NT 10-K
NT 10-Q
PRE 14A
RW
S-1
S-1/A
S-3
S-3/A
S-3ASR
S-3MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC 14F1
SC 14F1/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | — | 0001698262-25-000005 | Dec 29, 2025 | Dec 24, 2025 |
| 4 | — | 0001882909-25-000006 | Dec 16, 2025 | Dec 15, 2025 |
| 144 | — | 0001950047-25-010276 | Dec 15, 2025 | — |
| 4 | — | 0001943192-25-000005 | Dec 3, 2025 | Dec 1, 2025 |
| 144 | — | 0001950047-25-009511 | Dec 1, 2025 | — |
| SCHEDULE 13G/A | — | 0001172661-25-005160 | Nov 14, 2025 | — |
| 4 | — | 0001882909-25-000004 | Nov 6, 2025 | Nov 4, 2025 |
| 4 | — | 0001376043-25-000004 | Nov 4, 2025 | Oct 31, 2025 |
| 144 | — | 0001950047-25-008434 | Nov 4, 2025 | — |
| 4 | — | 0001789617-25-000007 | Nov 4, 2025 | Oct 31, 2025 |
| 144 | — | 0001959173-25-006629 | Oct 31, 2025 | — |
| 144 | — | 0001957799-25-000224 | Oct 31, 2025 | — |
| 4 | — | 0001763494-25-000005 | Oct 30, 2025 | Oct 28, 2025 |
| 10-Q | 10-Q | 0001438533-25-000056 | Oct 30, 2025 | Sep 30, 2025 |
| 4 | — | 0001789617-25-000006 | Oct 30, 2025 | Oct 28, 2025 |
| 8-K | 8-K | 0001438533-25-000055 | Oct 30, 2025 | — |
| 144 | — | 0001959173-25-006603 | Oct 29, 2025 | — |
| 144 | — | 0001959173-25-006592 | Oct 28, 2025 | — |
| 144 | — | 0001959173-25-006585 | Oct 28, 2025 | — |
| SCHEDULE 13G | — | 0001193125-25-238357 | Oct 14, 2025 | — |
| 4 | — | 0001789617-25-000004 | Sep 24, 2025 | Sep 23, 2025 |
| 4 | — | 0001283303-25-000005 | Sep 24, 2025 | Sep 22, 2025 |
| 144 | — | 0001950047-25-007388 | Sep 22, 2025 | — |
| 8-K | 8-K | 0001438533-25-000049 | Sep 10, 2025 | — |
| 4 | — | 0001415889-25-023786 | Sep 5, 2025 | Sep 3, 2025 |
| 4 | — | 0001415889-25-023209 | Aug 28, 2025 | Aug 27, 2025 |
| SCHEDULE 13G/A | — | 0001172661-25-003635 | Aug 15, 2025 | — |
| 8-K | 8-K | 0001438533-25-000045 | Aug 6, 2025 | — |
| 10-Q | 10-Q | 0001438533-25-000046 | Aug 6, 2025 | Jun 30, 2025 |
| SCHEDULE 13G/A | — | 0000932471-25-001051 | Jul 29, 2025 | — |
| 4 | — | 0001415889-25-019108 | Jul 2, 2025 | Jul 1, 2025 |
| S-8 | S-8 | 0001438533-25-000038 | Jun 17, 2025 | — |
| 4 | — | 0001415889-25-013499 | May 16, 2025 | May 15, 2025 |
| 4 | — | 0001415889-25-013502 | May 16, 2025 | May 15, 2025 |
| 8-K | 8-K | 0001438533-25-000034 | May 16, 2025 | May 15, 2025 |
| 4 | — | 0001415889-25-013503 | May 16, 2025 | May 15, 2025 |
| 4 | — | 0001415889-25-013496 | May 16, 2025 | May 15, 2025 |
| 4 | — | 0001415889-25-013497 | May 16, 2025 | May 15, 2025 |
| 4 | — | 0001415889-25-013498 | May 16, 2025 | May 15, 2025 |
| 4 | — | 0001415889-25-013504 | May 16, 2025 | May 15, 2025 |
| 4 | — | 0001415889-25-013500 | May 16, 2025 | May 15, 2025 |
| 4 | — | 0001415889-25-013501 | May 16, 2025 | May 15, 2025 |
| 8-K | 8-K | 0001438533-25-000032 | May 15, 2025 | — |
| SCHEDULE 13G/A | — | 0000950170-25-071930 | May 15, 2025 | — |
| SCHEDULE 13G/A | — | 0001172661-25-002075 | May 15, 2025 | — |
| SCHEDULE 13G/A | — | 0001172661-25-002216 | May 15, 2025 | — |
| 4 | — | 0001415889-25-012056 | May 5, 2025 | May 2, 2025 |
| 4 | — | 0001415889-25-012057 | May 5, 2025 | May 2, 2025 |
| 4 | — | 0001415889-25-012058 | May 5, 2025 | May 2, 2025 |
| 4 | — | 0001415889-25-012061 | May 5, 2025 | May 2, 2025 |